MedTrace Logo

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

NCT03922594 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-05-20

No results posted yet for this study

Summary

This study will explore whether ZIKV is currently responsible for neurological complications, and particularly microcephaly, in Aedes-infested regions of Sub-Saharan Africa (SSA) and Asia. This will inform regional public health strategies, such as vaccination of women of child-bearing age. It will also demonstrate the public health impact of ZIKV infection and increase the understanding of other regional infectious (e.g. cytomegalovirus) causes of microcephaly.

Conditions

  • Microcephaly
  • Congenital Infection

Interventions

DIAGNOSTIC_TEST

Differential diagnosis for infectious causes of microcephaly

Zika virus, cytomegalovirus, rubella, toxoplasmosis

Sponsors & Collaborators

  • Centre Pasteur du Cameroun

    collaborator OTHER

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Institut Pasteur of Cote d'Ivoire

    collaborator OTHER_GOV

  • Pasteur Institute, Ho Chi Minh City

    collaborator OTHER_GOV

  • Tu Du Hospital

    collaborator OTHER_GOV

  • Perinatal Society of Sri Lanka

    collaborator UNKNOWN

  • University of Colombo

    collaborator OTHER

  • University of Lausanne

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • The University of Hong Kong

    collaborator OTHER

  • Ministry of Health of Sri Lanka

    collaborator UNKNOWN

  • Central Hospital Maternity

    collaborator UNKNOWN

  • Essos Hospital Center

    collaborator OTHER

  • Guangzhou Baiyun Maternal and Child Health Hospital

    collaborator UNKNOWN

  • General Hospital of Yopougon-Attie

    collaborator UNKNOWN

  • General Hospital Abobo-Sud

    collaborator UNKNOWN

  • Castle Street Hospital for Women

    collaborator UNKNOWN

  • De Soyza Hospital for Women

    collaborator UNKNOWN

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Arnaud Fontanet · Institut Pasteur

Eligibility

Min Age
0 Days
Max Age
2 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Cameroon
  • China
  • Côte d’Ivoire
  • Sri Lanka
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03922594 on ClinicalTrials.gov